MedPath

Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor

Not Applicable
Completed
Conditions
Labor
Interventions
Registration Number
NCT07184099
Lead Sponsor
Muhammad Aamir Latif
Brief Summary

This study was planned to fill the gaps regarding the effectiveness of phloroglucinol on the duration of active phase of labor.

Detailed Description

In today's era, the focus has shifted from a "wait and watch" policy to "active intervention sooner than later" to enhance better labor outcomes. Using an ideal antispasmodic drug would help achieve a rapid and prolonged effect on cervical dilation, with no adverse impact on uterine contractions or causing uterine inertia. If the current study finds phloroglucinol effective in shortening the duration of the active phase of labor, it would help achieve better patient outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
134
Inclusion Criteria
  • Pregnant women aged between 18-35 years
  • Period of gestation above 37 weeks.
Exclusion Criteria
  • Women with cephalopelvic disproportion
  • Double scare uterus
  • Fetal distress
  • Life threatening bleeding
  • Eclampsia
  • History of heart disease
  • Known allergy to phloroglucinol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Phloroglucinol groupPhloroglucinolPhloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.
Primary Outcome Measures
NameTimeMethod
Duration of labor4 hours

The duration of labor was measured from the time of diagnosis of labor until full dilatation of cervix.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Combined Military Hospital

🇵🇰

Attock, Punjab Province, Pakistan

Combined Military Hospital
🇵🇰Attock, Punjab Province, Pakistan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.